Tag: Sunovion Pharmaceuticals
Lupin rolls out Lurasidone Hydrochloride in US for bipolar depression
Lupin Limited said that it has rolled out Lurasidone Hydrochloride Tablets in the strengths of 20mg, 40mg, 60mg, 80mg, and 120mg in the US. Lurasidone ... Read More
Lupin to acquire rights to Brovana and Xopenex HFA for $75m
Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) ... Read More
Lupin Limited launches generic of Arformoterol Tartrate in US
Lupin Limited said that it has launched the authorized generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcg /2 mL, unit-dose vials, of Sunovion ... Read More
Alembic Pharmaceuticals gets FDA approval for Lurasidone Hydrochloride Tablets
Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lurasidone Hydrochloride Tablets, ... Read More
FDA refuses to approve Sunovion ADHD drug dasotraline
FDA decision on Sunovion ADHD drug approval : The US Food and Drug Administration (FDA) has refused to approve Sunovion Pharmaceuticals’ dual-acting dopamine and norepinephrine ... Read More